Can lenalidomide play a role in the management of scleritis?

Lenalidomide is an immunomodulatory agent that was approved for the treatment of a monoclonal bone marrow disorders, myelodysplastic syndrome del(5q)(MDS del(5q)), in 2005; the drug was subsequently also approved for the treatment of refractory multiple myeloma, a bone marrow malignancy of the B-lym...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Al-Jafar, Hassan A, Abul, Nadia, Kumar, Niranjan, Al-Awadhi, Adel
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2013
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3702810/
https://ncbi.nlm.nih.gov/pubmed/23780766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2013-009092
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker